E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/31/2005 in the Prospect News Convertibles Daily.

S&P: ORIX unaffected

Standard & Poor's said that ORIX Corp.'s (BBB+/stable/--) plan to inject capital into Daikyo Inc. (NR) would not affect its ratings on the company.

According to Monday's announcement, ORIX plans to invest ¥63 billion in Daikyo in the form of common stock, preferred stock, and a loan facility. ORIX is expected to become the largest shareholder, controlling slightly more than 40% of voting rights in Daikyo.

S&P said the negative impact on ORIX from the capital injection should be minimal, given Daikyo's improving credit quality due to write-offs of unrealized losses through financial support from its main banks, as well as restructuring in order to focus its strategy on its core business. Furthermore, ORIX's solid capitalization at ¥619.2 billion as of September 2004 should be able to withstand the increase in risk as a result of this capital injection.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.